当前位置: 首页 > 详情页

Outcome in Acute Stroke with Different Intra-Arterial Infusion Rate of Urokinase on Thrombolysis

| 导出 | |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Xuanwu Hospital, Capital Medical University, Beijing, China
出处:
ISSN:

关键词: autologous blood clot embolism urokinase intra artery thrombolysis infusion

摘要:
Intra-arterial infusion of urokinase (UK) has been widely used However, the optimal infusion rate of the reagent has never been determined This was investigated in the acute stage of middle cerebral artery (MCA) embolism in the present study Sprague Dawley male rats (n=43) were randomly divided into sham-operation and five ischemic groups with urokinase administration at different infusion rates or without urokinase administration Ischemia was induced with MCA embolism Two hours after embolism, total urokinase (urokinase, 170,000U/kg) was given in groups A,B,C and D (n=8 each) at different rates 1,000 U (0 03 ml/min) per minute, 4,000U (0 12 ml/min), 10,000U (0 30 ml/min), and 16,000U (0 48 ml/min), respectively Group E received normal saline at a rate of 0 48 ml/min The sham-operation group (no embolism) received urokinase at (170,000U/kg, 1 5 ml, 16,000 U/min) During ischemia and thrombolysis, regional cerebral blood flow (CBF) was monitored by laser Doppler flowmetry The neurological deficits, Infarct volumes and mortalities in each group were determined The CBF in ischemic hemisphere were significantly (p<0 05) decreased after embolism in groups A similar to E at similar levels (27 32 +/- 8 20% to 34 71 +/- 6 84%) After different treatments, in group B 4,000U/min infusion of UK induced the best reperfusion, the least neurological deficits and infarct volume, as well as the least mortality and lowest Incidence of hemorrhage The effect of intra-artery thrombolysis of urokinase was related to the infusion rate Our study demonstrated an optimal infusion rate at 4,000U/min, suggesting relatively low levels of infusion are better able to improve brain reperfusion and reduce brain injury after stroke

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2009]版:
大类 | 4 区 医学
小类 | 4 区 临床神经病学 4 区 核医学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 临床神经病学 4 区 核医学
JCR分区:
出版当年[2008]版:
Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Q4 CLINICAL NEUROLOGY
最新[2023]版:
Q3 CLINICAL NEUROLOGY Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Q4 CLINICAL NEUROLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2008版] 出版当年五年平均 出版前一年[2007版] 出版后一年[2009版]

第一作者:
第一作者机构: [1]Xuanwu Hospital, Capital Medical University, Beijing, China
通讯作者:
通讯机构: [*]Department Cerebral Vascular Disease Institute, Neurosurgery Department Institution, Xuanwu Hospital Capital, Medical University Changchun, Street No. 45 Xuanwu District Beijing, 100053 China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院